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Surfactant Protein Expression in Human Skin:
Evidence and Implications
Young-Keun Mo1, Orhan Kankavi1, Paul P. Masci1, George D. Mellick2, Michael W. Whitehouse1,
Glen M. Boyle3, Peter G. Parsons3, Michael S. Roberts1 and Sheree E. Cross1
The presence of surfactant proteins (SPs), critical to local barrier and defense functions and usually associated
with the lung, was revealed in adult and fetal human skin complementary deoxyribonucleic acid, in skin
samples from three adult female donors and also in cultured fibroblasts, keratinocytes, and melanocytes. Using
reverse transcription-PCR, SP-A, SP-B, SP-C, and SP-D messenger ribonucleic acid expression was detected to
varying extents in the different skin sources. The stronger expression of SP-C in fetal skin, compared to adult
skin, suggested that the role of this protein alters with age. Immunohistochemical studies showed variable
distribution of SPs in human epidermis and dermis, confirming that these proteins are indeed translated and
expressed in skin tissue. In vitro studies showed that the surface tension of SP-deficient artificial sebum is
(a) lowered by skin-extracted SP-B and (b) further reduced to a level comparable to normal sebum by the
additional presence of skin-extracted SP-A and SP-D, consistent with their surface tension-lowering capabilities
in lung. The possible roles of SPs in skin, based on their known functions in the lung are discussed. However,
their potential as therapeutic targets or diagnostic markers of skin disease remains to be elucidated.
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INTRODUCTION
The skin provides the principal physical barrier to the
environment (Spellberg, 2000), functions as a component of
the immune system, and provides non-specific and specific
defenses against foreign antigens. The recognition, and
reaction against, foreign bodies is a complex process
involving an array of cytokines, various binding proteins,
and also surfactant proteins (SPs) A and D (Minchinton et al.,
2004).
Originally, SPs were recognized as merely carriers of
broncoactive phospholipid surfactants, but are now recog-
nized as important host defense components. SP-A and SP-D
are predominant in the small airways and gas exchange units
of the lung (Pison et al., 1994) and are members of the
calcium-dependent multimeric collagenous lectins referred
to as collectins, together with mannose-binding proteins and
bovine conglutinin (Holmskov and Jensenius, 1993). SP-A
and SP-D can mediate the clearance of pathogens and
modulate immune cell function (Crouch and Wright, 2001).
Although localization of SP-A and SP-D within the lung is
well characterized (Voorhout et al., 1991, 1992), recent
studies have also suggested that these proteins might be
present in small amounts in extrapulmonary tissues and
organs (van Rozendaal et al., 2001).
Extrapulmonary distribution of SP-A and SP-D messenger
ribonucleic acid (mRNA) and translated protein distribution
has been shown in cells lining epithelial surfaces and
glandular cells that are in direct or indirect continuity with
mucosal surfaces, such as gastric mucosa (Fisher and Mason,
1995), mesentery cells (Chailley-Heu et al., 1997), large
intestine (Lin and Floros, 2002), Eustachian tube epithelium
(Paananen et al., 2001), and the female genital tract (Leth-
Larsen et al., 2004). This pattern of widespread distribution
raises the question as to whether potential innate immune
functions of SP-A and SP-D are shared across body sites,
particularly those coming into contact with external or
ingested pathogens.
The two hydrophobic SPs (B and C), essential for reducing
surface tension together with phospholipids (Brockman et al.,
2003), were also traditionally thought to be restricted to respi-
ratory epithelia. However, recent evidence from Paananen
et al. (2001) suggests the presence of SP-B outside the lung in
porcine Eustachian tube epithelium.
As the skin is the largest organ of the body exposed
directly to external pathogens, we hypothesized that SPs may
be present in skin with some putative functional role similar
to that exerted in other tissues. This present investigation
examined the expression of SPs in human skin and iso-
lated human skin cell lines using reverse transcription-PCR
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RESULTS
SP mRNA expression in human skin
Commercial adult and fetal skin cDNA. Figure 1 illustrates
the expression profiles of the SPs obtained from RT-PCR on
commercially available adult human skin Gene PoolTM
complementary deoxyribonucleic acid (cDNA), fetal skin
Gene PoolTM cDNA, and control human lung tissue. For SP-A,
primary PCR products were absent, but secondary nested
PCR signal was observed for both adult and fetal skin cDNA.
The expression of SP-B and SP-D was observed in both adult
and fetal skin. SP-C expression was observed only in fetal skin
Gene PoolTM cDNA.
Human skin cell lines. The expression profiles for the various
SPs in human skin cells, as assessed by RT-PCR, are presented
in Figure 2a. The genetic message for SP-B and SP-D was
detected in all skin cell types examined and the skin cell lines
(HaCaT and Colo16). SP-A expression following nested PCR
was observed only in melanocyte and the two keratinocyte
cell lines. SP-C expression was not observed in fibroblasts
and was only weakly observed in keratinocytes and
keratinocyte cell lines.
Human skin samples. RT-PCR analysis of individual skin
samples and control lung showed SP-B, SP-C, and SP-D
expression in all donors (Figure 2b). SP-A expression was
observed in the two abdominal but not breast skin donors
(following secondary nested PCR). Although of similar sizes
to those from human lung, expression in skin was markedly
lower. Expression of b-actin, used as a housekeeping gene,
was essentially not different among various skin donors.
Sequencing of the amplified RT-PCR products from human
skin samples showed identical sequences to the consensus
sequences for pulmonary SPs listed in the National Center for
Biotechnology Information database.
Immunohistochemical analysis of SP expression
Strong staining of SP-A was seen in the epidermis of human
skin (Figure 3). This staining was also observed throughout
the layers of the stratum granulosum and stratum corneum to
the skin surface. The presence of SP-D was observed in
epidermal layers including the stratum spinosum, stratum
lucidium, and stratum granulosum, and was visible on the
outer surface of the stratum corneum (Figure 3). In a different
skin donor, the pattern of SP-A and SP-D antibody-specific
staining of proteins in the epidermis (Figure 4) is consistent
with that observed in Figures 3 and 4. In addition, SP-D
reactivity was also noticed in the dermis, although the
structures responsible for this staining have not been
identified. For this donor, SP-B antibodies were available
and showed intense staining through the stratum lucidium,
stratum granulosum, and stratum corneum. Staining for SPs
was also observed around the hair follicle shaft; although
sections were taken at different depths, a definitive pattern of
distribution could not be obtained. SP-A stained quite
intensely throughout the outer and inner root sheath, whereas
SP-B and SP-D seemed to have a much lower and diffuse
staining through these structures. In a more recent study,
when SP-C antibodies became available, reactivity to SP-C
appeared to be limited to the basement membrane of the
epidermis and present in the sebaceous glands of the hair
follicles (Figure 5).
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Figure 1. RT-PCR analysis of SPs genes. Human adult normal skin Gene
PoolTM (AGP), human fetal normal skin Gene Pool TM (FGP), and human
normal lung (L) showed clear bands for SP-A, SP-B, SP-C, and SP-D cDNA.
M represents DNA weight marker. B represents blank without cDNA.
a bHuman cultured cell lines Human skin samples









Figure 2. RT-PCR analysis of SP genes from fresh skin. SP-A, SP-B, SP-C, and
SP-D mRNA expression in (a) human cells (M: DNA size marker, L: Lung,
F: neonatal fibroblasts, Me: melanocytes, K: keratinocytes, H: HaCaT,
C: Colo16, B: blank without cDNA) and (b) human from normal female
abdomen (S1: 42-year old), normal female breast (S2: 44-year old), and
normal female abdomen (S3: 40-year old).
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SP effects on monolayer surface tension
In surface tension studies, skin SP-A and SP-D did not affect
the organization of monolayers of artificial sebum. However,
a significant reduction in surface tension was obtained when
artificial sebum was mixed with 1% skin SP-B (Figure 6).
Unfortunately, sufficient quantities of skin SP-C could not be
isolated for inclusion in these surface tension studies. Adding
all three available skin SPs into the artificial sebum mixture
decreased surface tension to a greater extent than adding skin
SP-B alone. Normal healthy sebum reduced surface tension
more efficiently than the artificial sebum mixture when mixed
with the skin SPs. Normal sebum, as obtained by organic
solvent extraction, may already contain SP-B (which would
partition into the organic phase owing to its more lipophilic
nature compared to the other SPs). A further lowering of
surface tension was observed with the addition of skin SP-A
and SP-D to normal sebum.
DISCUSSION
This report comprehensively describes, for the first time, the
presence of SPs in human skin and human skin-derived cell
lines. Human fetal skin showed strong mRNA expression
of SP-B and SP-C, compared to adult skin. SP-A mRNA was
only present in very small amounts, whereas SP-D seemed to
be strongly expressed by both fetal and adult samples,
supporting the idea that SP-D is expressed broadly in extra
pulmonary tissues. In addition, these immunohistochemical
studies of skin sections showed that, in female adult skin, the
SP-A, SP-B, and SP-D proteins could all be detected in
the epidermis, whereas SP-C was mainly associated with
the basal layer of the epidermis and sebaceous glands.
Human skin cells grown in culture provided further clues as
to the potential sources of these proteins in the skin, with
melanocytes and certain immortalized keratinocyte cell lines
(HaCaT and Colo16), though not those taken from neonatal
foreskins, expressing mRNA for all four SPs studied.
Furthermore, skin fibroblasts appeared to express SP-B and
SP-D mRNA, meaning that among these cell populations the
potential exists for synthesis of SPs, under appropriate
stimulatory conditions, in most areas of the skin.
The presence of SP-A and SP-D in the outer layers of the
epidermis, stratum corneum, and stratum lucidium, in
addition to the viable epidermis was interesting as it is within
these layers of the skin that contact with microbial or other





Figure 4. Immunohistochemical localization of SP-A, SP-B, and SP-D in
normal human skin from a second donor. (a) Skin control, without primary
antibody, (b) hair shaft control, without primary antibodies, (c) SP-A
immunoreactivity in human skin, (d) SP-A immunoreactivity in hair shaft,
(e) SP-B immunoreactivity in human skin, (f) SP-B immunoreactivity in hair
shaft, (g) SP-D immunoreactivity in human epidermis, and (h) SP-D
immunoreactivity in hair shaft. Bar¼200 mm (a, c, e, g) and 100 mm





Figure 3. Immunohistochemical detection of SP-A and SP-D in human
lung and skin. Immunostaining staining without primary antibodies reveals
absence of SP-A immunoreactivity in (a) lung and (c) skin compared to SP-A
positive antibody staining for (b) lung and (d) skin. Immunostaining staining
without primary antibodies reveals absence of SP-D immunoreactivity in
(e) lung and (g) skin compared to SP-D-positive antibody staining for (f) lung
and (h) skin. Bar¼ 100mm.
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defense mechanisms protecting the skin are still evolving.
The now confirmed expression of SP-A and SP-D at these
sites suggests that the innate immune protection they offer in
the lung could also be available as one part of the skin’s
overall protective mechanisms against external assault.
The two hydrophobic SPs (SP-B and SP-C) were observed
in the skin, although SP-C mRNA was more readily
detectable in fetal cDNA samples compared to adult, and
observed in the two human abdominal skins but not breast
skin sample examined. The surfactant properties provided by
SP-B and SP-C may contribute to the even spreading of fluids,
such as sebum, across the skin surface to maintain normal
skin moisturization and surface lubrication. This may also be
the reason why SP-C mRNA was expressed more readily in
fetal skin, at an earlier stage of barrier development, than in
the adult skin samples. However, the adult Gene Pool skin
cDNA was taken from a 92-year old and may not be
representative of normal expression in a younger adult
population.
The differential expression of both SP-A and SP-C mRNA in
the abdominal compared to breast skin is suggestive of
regional variation; however, a larger number of samples
would be required to validate this. The lack of observation of
SP-A expression in keratinocytes, yet detection in abdominal
skin mRNA and visibility in immunohistochemical studies is
also suggestive of possible variability in expression, again
owing to either anatomical region (keratinocytes being har-
vested from neonatal foreskins) or stage of cell differentiation.
Lowering the surface tension of sebum facilitates its
spreading over the skin’s surface and its ability to ‘‘wet’’ the
outer surface of any material coming into contact with the
skin. It is known that immunoprotectant proteins cannot
recognize foreign bodies if they are unable to come into
adequate contact with the material’s surface. In the lung, this
is achieved by the spreading of bronchial fluid over the
material. Our functional surface tension studies, using SPs
extracted from human skin samples, indicate that SPs on the
skin surface could likewise facilitate the ‘‘wetting’’ of a
foreign body.
The function of SP-D is presumed to be defensive,
restricting entry of organisms that may cause disease.
Previous studies suggest that serum SP-D levels are
genetically determined (Husby et al., 2002) and that certain
SP-D alleles alter the risk of infection by severe respiratory
syncytial virus and mycobact tuberculosis (Floros et al.,
2000 and Lahti et al., 2002). Perhaps, different allelic
variants of SP-A or SP-D might similarly influence the
susceptibility to skin infection. SP-A and SP-D share
structural similarities to C-type lectins, such as L-selectin
which has been shown to have a range of immunoregulant
and inflammation-mediating properties (Kishore et al.,
2006). Lung SP-A and SP-D are known to inhibit allergen-
induced proliferation of lymphocytes and histamine release
from whole blood of atopic donors in response to the house
dust mite, suggesting that lung surfactants may help
moderate asthma pathogenesis (Wang et al., 1998, 2001).
Perhaps, changes in the availability of skin surfactants may
play a role in atopic eczema (a chronic inflammatory skin
condition affecting mainly children), which has a strong
genetic link with other atopic conditions such as asthma,
hay fever, or urticaria.
In summary, data presented here support the conclusion
that SPs are expressed in human skin at both the mRNA and
protein level, and given their known function in the lung,
could be associated with defense against local infections and
other skin diseases. These findings have significant implica-
tions on the way we consider immune responses in the skin;
however, further studies are needed to determine the exact
functional role of these proteins within the skin’s complex
a b
c d
Figure 5. Immunohistochemical localization of SP-C in normal human skin
and sebaceous gland. Control sections without primary antibody for (a) skin
and (b) sebaceous gland, and respective antibody-stained sections for (c) skin
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Figure 6. Surface tension-reducing effects of skin SP (1% A, B, and D) from
skin measured by the Wilhemy balance. Data shown is the average of
duplicates. NS: normal sebum, AS: artificial sebum. (Insufficient skin SP-C
was available for inclusion in this analysis.)
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immune defense system, how this might be subverted in
various skin disorders and more importantly, does the
regulation of SP availability represents a potential therapeutic
target for treating some presently intractable skin diseases.
MATERIALS AND METHODS
Materials
Human fetal skin cDNA (40 weeks, female, Gene PoolTM cDNA
(Invitrogen, Carlsbad, CA), Human adult normal skin cDNA (92-year
old, Gene PoolTM cDNA, Invitrogen, containing epidermis and
dermis) and human normal skin (three female surgical donors) were
used in PCR experiments. All studies were conducted with ethical
approval from University of Queensland and Princess Alexandra
Hospital Ethical Experimentation and Research Committees.
Isolation and culture of human normal melanocytes
Human melanocytes were isolated from infant male foreskin. Tissue
was cut into 5 5 mm pieces and incubated with collagenase
(Dispase grade II) (2.4 U/ml) for 2 hour at 371C. Epidermis fragments
were transferred into a 0.05% trypsin – 0.02% EDTA solution for
1 minute to dissociate cells. After centrifugation (1,200 g, 5 minutes),
the pellet was removed and cells were suspended in growth
medium. Melanocytes were cultured at 371C in a humidified
atmosphere containing 5% CO2 in Rosewell Park Memorial Institute
medium-1640, supplemented with 10% fetal bovine serum, 100 U/
ml penicillin, 100 mg/ml streptomycin, 0.6 mg/ml cholera toxin, and
10 ng/ml 12-O-tetradecanoyl-phorbol-13-acetate.
RNA extraction
(i) Lung and tissues. Total cellular RNA was prepared from frozen
lung tissue by an acid–phenol extraction method using a commer-
cially available reagent according to the manufacturer’s directions
(Trizol, BRL life Technologies, NY). Frozen lung (120 mg) and skin
(90–130 mg) tissues were homogenized with TRIzol using a Polytron
homogenizer. The aqueous phase obtained from the TRIzol
extraction contained total RNA, which was precipitated by mixing
with isopropyl alcohol. After incubating the mixture at 41C over-
night, it was centrifuged at 12,000 g for 10 minutes at 41C. The RNA
precipitate was washed with 70% ethanol and re-suspended in water
and stored at 701C.
(ii) Cell lines. Total cellular RNA from fibroblasts, keratinocytes,
melanocytes, HaCaT (immortalized keratinocyte cell line), and
Colo16 (squamous-cell carcinoma line) was isolated from sub-
confluent cell cultures grown in three T150 flasks by the RNeasy
Midi procedure (Qiagen, Germany), as per the manufacturer’s
instructions.
RT-PCR analysis
First-strand cDNA species was synthesized from 2 mg of RNA species
by the Oligo (dT) priming method with Moloney murine leukemia
virus reverse transcriptase (Ambion, RETROcript, Austin, TX). A 2mg
of total RNA was added to 1 ml Oligo (dT) (50 mM) and made up to a
final volume of 12 ml with nuclease-free water. The reaction mixture
was then denatured at 801C for 3 minutes and placed on ice. To this
reaction was added 2ml of 10 RT buffer (500 mM Tris-HCl (pH
8.3), 750 mM KCl, 30 mM MgCl2, and 50 mM dithiothreitol), 1ml
RNase inhibitor (10 U/ml), 4ml deoxynucleoside triphosphate mix
(2.5 mM each deoxynucleoside triphosphate), and 1 ml Moloney
murine leukemia virus reverse transcriptase (100 U/ml). The mixture
was first heated to 431C for 1 hour, then 921C for 10 minutes. The
30 ml total PCR volume consisted of 3ml of cDNA, 1 U of Taq
polymerase, 3 ml of 10 PCR buffer, 1.5 ml of deoxynucleoside
triphosphate mix, and 1.5 ml of PCR primers (mixture with 5mM of
each primer). The sequences of the oligonucleotides used for the
PCR amplifications are available as Supplementary Material to this
paper. The PCR reaction was then performed in a thermocycler
under the following conditions: 40 amplification cycles, denatura-
tion for 25 seconds at 941C, annealing for 25 seconds at 60–621C,
and extension for 50 seconds at 721C. In general, amplifications
were performed using an MgCl2 concentration of 1 mM and an
annealing temperature of 621C. The exception was for SP-A, in
which case a nested RT-PCR approach was used. A total of 12.5 ml of
each PCR product was electrophoresed in a 2% agarose gel
containing ethidium bromide. As a PCR control, a b-actin gene
fragment was amplified simultaneously with oligonucleotide primers
for SPs.
Nested RT-PCR analysis
An initial amplification was performed as described above but with
an MgCl2 concentration of 1.5 mM, and an annealing temperature of
601C. Twenty-five cycles were employed. A 2ml of the resultant first-
round product was then amplified with a second round of PCR
together with 1 U of Taq polymerase, 3ml of 10 PCR buffer, 1.5 ml
of deoxynucleoside triphosphate mix, and 3ml of PCR primers
(mixture with 5 mM of each primer). The PCR reaction (25 cycles) was
then performed in a thermocycler under the following conditions:
denaturation for 25 seconds at 941C, annealing for 25 seconds at
581C, and extension for 50 seconds at 721C. A total of 10ml of each
PCR product was electrophoresed in a 2% agarose gel containing
ethidium bromide.
Cloning of cDNA fragments for skin SPs
The resulting fragments were purified using a PCR purification kit
(Qiagen) and ligated to the pGEM-T vector (Promega, Madison, WI).
Plasmids were purified using the QIAprep Spin Miniprep Kit
(Qiagen) and the resultant clones identified by sequencing using
an ABI Prism 3100 Genetic Analyzer (Hitachi/Applied Biosystems,
Foster City, CA). Sequences were analyzed against the GenBank
database using BLASTN via the National Center for Biotechnology
Information genomic information service program.
Immunohistochemistry
Human lung and skin tissues were dissected, covered in tissue-
freezing medium (Tissue-Tek, Torrance, CA), and frozen in dry ice
and kept at 701C. Immunohistochemistry was performed on
cryosections of 5–8mm thickness, which had been mounted and
dried overnight at room temperature before fixation. Sections were
fixed in ice-cold acetone for 5 minutes and rinsed three times in
phosphate-buffered saline (PBS), pH 7.4. Endogenous peroxidase
activity was blocked by incubating the section in PBS buffer
containing 1% hydrogen peroxide and 0.1% sodium azide, for
10 minutes. Sections were washed in three changes of PBS for
5 minutes each. The sections were pre-incubated in blocking buffer
(10% normal donkey serum in PBS) for 30 minutes. Excess blocking
solution was decanted from the sections. Primary antibodies (mouse
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anti-human SP-A mAb: DACO PE10 (Kent, WA); sheep anti-human
SP-B and SP-C polyclonal antibodies: Santa Cruz Biotechnology
(Santa Cruz, CA); and rabbit anti-human SP-D polyclonal antibody:
Chemicon (Temecula, CA)) were diluted in PBS buffer (the dilution
factor was 1:50) and sections were incubated overnight at room
temperature. After incubation, samples were rinsed three times for
5 minutes in PBS. Incubation with the secondary antibody (Chemi-
con sheep anti-mouse for SP-A, donkey anti-sheep for SP-B and SP-
C, and sheep anti-rabbit for SP-D) was performed at a 1:200 dilution
in PBS buffer for 1 hour at room temperature. After rinsing the
sections three times for 5 minutes in PBS, the color was developed in
3,3-diaminobenzidine with hydrogen peroxide for 5–20 minutes.
After color development, slides were counterstained with Mayers’
hematoxylin, then dehydrated through ascending graded alcohols,
cleared in xylene, and mounted with coverslips. Controls were
incubated with PBS alone without primary antibody.
Collection of human sebum
Sebum was collected from the forehead of volunteers using either
filter paper or cleansing the forehead with methanol. Lipids in the
filter paper were extracted with chloroform:methanol (2:1 v/v)
overnight at 41C and total lipid content measured so that 300 mg total
lipid could be used for both artificial and human sebum in surface
tension studies.
Purification of SPs from skin tissues
Skin (275 g) was incubated with dispase (1.2 Us/mg, GibcoBRL Life
Technologies, Invitrogen, Carlsbad, CA) at 41C overnight, before the
epidermis was peeled from the dermis. The epidermis was
homogenized (3 10 seconds bursts) in 0.15 M NaCl, with 0.005 M
EDTA at pH 7.4. Cells and debris were removed by centrifugation
at 41C. SP-A was isolated from the resultant pellets, whereas SP-D
was isolated from the supernatant using maltosyl-agarose-packed
glass columns. Epidermal SPs were used in surface tension studies.
Isolation of skin SP-B
Centrifuged pellets were also extracted with chloroform/methanol
(2:1 v/v) at 41C; organic phases were collected, concentrated, and
chromatographed on Sephadex LH-20 and LH-60 columns. The
purity of the SPs was determined using SDS-PAGE.
SP effects on monolayer surface tension
Surface tension studies were carried out using the Langmuir-Adam
trough with a platinum dipping plate to measure surface tension
(Hills, 2000). Six cycles were carried out at room temperature with
each combination of surfactant mixtures. Artificial sebum was a
mixture of 15% squalene, 1% cholesterol, 2% cholesterol oleate,
10% palmitoleic acid, 14% tripalmitin, 28% triolein, and 25% oleic
acid dissolved in hexane:methanol (9:1). The total lipids used in
each monolayer study were 300 mg.
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